Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -287,100 | -241,375 | -202,847 | -172,947 | 132,244 |
| Depreciation Amortization | 3,454 | 2,618 | 1,726 | 849 | 2,888 |
| Accounts receivable | 34,062 | 20,722 | 15,243 | 16,663 | -15,218 |
| Accounts payable and accrued liabilities | 874 | 30,495 | -773 | 203 | -9,820 |
| Other Working Capital | 44,567 | 62,969 | 30,651 | 6,392 | -34,651 |
| Other Operating Activity | 166,711 | 139,461 | 157,179 | 150,207 | 78,702 |
| Operating Cash Flow | $-37,432 | $14,890 | $1,179 | $1,367 | $154,145 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,289 | -821 | -560 | -145 | -7,231 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 175 |
| Purchase Of Investment | -182,485 | -171,779 | -140,330 | -140,330 | -273,845 |
| Sale Of Investment | 181,364 | 62,700 | 15,000 | N/A | 274,000 |
| Other Investing Activity | -136,000 | -136,000 | -136,000 | -145,000 | -7,500 |
| Investing Cash Flow | $-138,410 | $-245,900 | $-261,890 | $-285,475 | $-14,401 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 222,156 |
| Debt Repayment | N/A | N/A | N/A | N/A | -18,170 |
| Common Stock Issued | 54,304 | 50,629 | 49,349 | 4,329 | 17,428 |
| Common Stock Repurchased | N/A | 1,985 | 1,985 | N/A | 3,801 |
| Other Financing Activity | -2,425 | -2,222 | -2,043 | -1,890 | -1,269 |
| Financing Cash Flow | $51,879 | $50,392 | $49,291 | $2,439 | $223,946 |
| Beginning Cash Position | 541,598 | 541,598 | 541,598 | 541,598 | 177,908 |
| End Cash Position | 417,635 | 360,980 | 330,178 | 259,929 | 541,598 |
| Net Cash Flow | $-123,963 | $-180,618 | $-211,420 | $-281,669 | $363,690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,432 | 14,890 | 1,179 | 1,367 | 154,145 |
| Capital Expenditure | -1,289 | -821 | -560 | -145 | -7,231 |
| Free Cash Flow | -38,721 | 14,069 | 619 | 1,222 | 146,914 |